VivoSeq
Other

Coenzyme Q10

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Coenzyme Q10 is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

6

clinical trials

Completed3 · 50%
Unknown status1 · 17%
Not yet recruiting1 · 17%
Active, not recruiting1 · 17%

Trial Activity

6 trials

Coenzyme Q10 and Dentoalveolar Cyst
Active, not recruiting·FFayoum University·Phase 2·NCT05873673·20 enrolled
Effect of Coenzyme Q10 on Diabetic Children
Not yet recruiting··Phase 1·NCT06361680·100 enrolled
Coenzyme Q10 in Older Athletes Treated With Statin Medications
Completed··Phase 4·NCT01026311·20 enrolled
Effects of Coenzyme Q10 in PSP and CBD
Completed·LLahey Clinic·Phase 2/3·NCT00532571
The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function
Unknown status··Phase 2·NCT05941910·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)